AAAAAA

   
Results: 1-3 |
Results: 3
A prospective randomised concurrent comparison of the COBE Spectra Version4.7, COBE Spectra Version 6 (auto PBSC (TM)) and Haemonetics MCS plus cellseparators for leucapheresis in patients with haematological and non-haematological malignancies
Authors: Green, RHA Watson, D Buchanan, S Morrison, AE
Citation: Rha. Green et al., A prospective randomised concurrent comparison of the COBE Spectra Version4.7, COBE Spectra Version 6 (auto PBSC (TM)) and Haemonetics MCS plus cellseparators for leucapheresis in patients with haematological and non-haematological malignancies, TRANSF AP S, 24(1), 2001, pp. 85-90
Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC (TM)), and haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies
Authors: Morrison, AE Watson, D Buchanan, S Green, RHA
Citation: Ae. Morrison et al., Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC (TM)), and haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies, J CLIN APH, 15(4), 2000, pp. 224-229
Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure
Authors: Clair, MJ King, MK Goldberg, AT Hendrick, JW Nisato, R Gay, DM Morrison, AE McElmurray, JH Krombach, RS Bond, BR Cazaubon, C Nisato, D Spinale, FG
Citation: Mj. Clair et al., Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure, J PHARM EXP, 293(3), 2000, pp. 852-860
Risultati: 1-3 |